BMJ Case Reports 2012; doi:10.1136/bcr-2012-006376
  • Novel treatment (new drug/intervention; established drug/procedure in new situation)

Chronic cystoid macular oedema treated with intravitreal dobesilate

  1. Guillermo Giménez-Gallego3
  1. 1Department of Research, Hospital Ramon y Cajal, Madrid, Spain
  2. 2Department of Ophthalmology, Hospital de Día Pio XII, Madrid, Spain
  3. 3Department of Qiimica de Proteinas, Centro de Investigaciones Biológicas, Madrid, Spain
  1. Correspondence to Professor Pedro Cuevas, pedro.cuevas{at}
  1. Competing interests None.

Dobesilate is an anti-inflammatory and antipermeability agent. Intravitreal administration of this compound is a therapeutically beneficial agent in the treatment of chronic cystoid macular oedema.


  • Patient consent Obtained.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article